Report copyright - New Treatments of Diabetic Nephropathyicnu.ir/uploads/manual/2016/ppt/2/A/930.pdfASCEND trial Endothelin receptor antagonist halted because of fluid overload and heart failure. Clinical
Please pass captcha verification before submit form